These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32760909)

  • 1. Physical stability and release properties of lumefantrine amorphous solid dispersion granules prepared by a simple solvent evaporation approach.
    Trasi NS; Bhujbal SV; Zemlyanov DY; Zhou QT; Taylor LS
    Int J Pharm X; 2020 Dec; 2():100052. PubMed ID: 32760909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
    Hiew TN; Zemlyanov DY; Taylor LS
    Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation.
    Bhujbal SV; Pathak V; Zemlyanov DY; Taylor LS; Zhou QT
    J Pharm Sci; 2021 Jun; 110(6):2423-2431. PubMed ID: 33387599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining drug salt formation with amorphous solid dispersions - a double edged sword.
    Hiew TN; Taylor LS
    J Control Release; 2022 Dec; 352():47-60. PubMed ID: 36206947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amorphous Drug-Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release.
    Neusaenger AL; Yao X; Yu J; Kim S; Hui HW; Huang L; Que C; Yu L
    Mol Pharm; 2023 Feb; 20(2):1347-1356. PubMed ID: 36668815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Polymer Architecture and Acidic Group Density on the Degree of Salt Formation in Amorphous Solid Dispersions.
    Neusaenger AL; Fatina C; Yu J; Yu L
    Mol Pharm; 2024 Jul; 21(7):3375-3382. PubMed ID: 38885189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-base interactions in amorphous solid dispersions of lumefantrine prepared by spray-drying and hot-melt extrusion using X-ray photoelectron spectroscopy.
    Song Y; Zemlyanov D; Chen X; Su Z; Nie H; Lubach JW; Smith D; Byrn S; Pinal R
    Int J Pharm; 2016 Dec; 514(2):456-464. PubMed ID: 27370910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the Dissolution Behavior of Ledipasvir-Copovidone Amorphous Solid Dispersions: Role of Drug Loading and Intermolecular Interactions.
    Que C; Lou X; Zemlyanov DY; Mo H; Indulkar AS; Gao Y; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Dec; 16(12):5054-5067. PubMed ID: 31689113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining enabling formulation strategies to generate supersaturated solutions of delamanid: In situ salt formation during amorphous solid dispersion fabrication for more robust release profiles.
    Duong TV; Nguyen HT; Taylor LS
    Eur J Pharm Biopharm; 2022 May; 174():131-143. PubMed ID: 35413402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
    Liu X; Zhou L; Zhang F
    Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
    Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
    J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.